≡

Tumor Protein D52 (TPD52)

[Edit]

PC-1; D52; N8L; PrLZ; hD52; Protein N8

Tumor Protein D52 (TPD52)
CCC H007
HGNC 12005
MGI 107749
PubMed 15986428
UniProt P55327
Wiki TPD52
D52 encodes a 184-amino acid polypeptide that includes a potential glycosylation site and several potential phosphorylation sites. The protein sequence has homology to N-type calcium channels. Northern blot analysis revealed a 3.3-kb D52 transcript in several human tissues and cell lines. D52 was expressed at significant levels in some breast carcinomas but at much lower levels in breast fibroadenomas.
D52 and D53 are coexpressed in some breast cell tumors and cell lines. Northern blot analysis showed that D52 and D53 transcription in breast carcinoma cells is dependent upon estradiol. D52 expression in HL-60 leukemia cells decreased following TPA-induced differentiation.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Tumor Protein D52 (TPD52) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Tumor Protein D52 (TPD52) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Tumor Protein D52 (TPD52) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Tumor Protein D52 (TPD52) CLIA Kit Customized Service Offer
n/a ELISA Kit for Tumor Protein D52 (TPD52) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Tumor Protein D52 (TPD52) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Tumor Protein D52 (TPD52) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Tumor Protein D52 (TPD52) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Tumor Protein D52 (TPD52) CLIA Kit Customized Service Offer
n/a ELISA Kit for Tumor Protein D52 (TPD52) ELISA Kit Customized Service Offer
  1. "A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence."Cancer Res. 55:2896-2903(1995) [PubMed] [Europe PMC] [Abstract]
  2. "Isolation and characterization of a novel gene expressed in multiple cancers."Oncogene 12:741-751(1996) [PubMed] [Europe PMC] [Abstract]
  3. "PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer."Cancer Res. 64:1589-1594(2004) [PubMed] [Europe PMC] [Abstract]
  4. "Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins."Biochem. Biophys. Res. Commun. 389:455-460(2009) [PubMed] [Europe PMC] [Abstract]
  5. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  6. "The full-ORF clone resource of the German cDNA consortium."BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract]
  7. "DNA sequence and analysis of human chromosome 8." Nature 439:331-335(2006) [PubMed] [Europe PMC] [Abstract]
  8. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  9. "Identification of homo- and heteromeric interactions between members of the breast carcinoma-associated D52 protein family using the yeast two-hybrid system."Oncogene 16:873-881(1998) [PubMed] [Europe PMC] [Abstract]
  10. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  11. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  12. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]